6.38
price up icon3.91%   0.24
after-market Handel nachbörslich: 6.39 0.010 +0.16%
loading
Schlusskurs vom Vortag:
$6.14
Offen:
$6.14
24-Stunden-Volumen:
127.32K
Relative Volume:
0.91
Marktkapitalisierung:
$242.14M
Einnahmen:
$239.40M
Nettoeinkommen (Verlust:
$104.44M
KGV:
2.1554
EPS:
2.96
Netto-Cashflow:
$-18.50M
1W Leistung:
+0.16%
1M Leistung:
-10.39%
6M Leistung:
-49.12%
1J Leistung:
-62.71%
1-Tages-Spanne:
Value
$6.13
$6.40
1-Wochen-Bereich:
Value
$6.12
$6.625
52-Wochen-Spanne:
Value
$6.12
$21.79

Entrada Therapeutics Inc Stock (TRDA) Company Profile

Name
Firmenname
Entrada Therapeutics Inc
Name
Telefon
857-305-1825
Name
Adresse
ONE DESIGN CENTER PLACE, BOSTON
Name
Mitarbeiter
183
Name
Twitter
Name
Nächster Verdiensttermin
2024-08-12
Name
Neueste SEC-Einreichungen
Name
TRDA's Discussions on Twitter

Vergleichen Sie TRDA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
TRDA
Entrada Therapeutics Inc
6.38 241.76M 239.40M 104.44M -18.50M 2.96
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
470.13 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.93 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.28 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
571.23 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.59 29.19B 3.81B -644.79M -669.77M -6.24

Entrada Therapeutics Inc Stock (TRDA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-12-06 Eingeleitet ROTH MKM Buy
2024-01-05 Eingeleitet Oppenheimer Outperform
2023-04-03 Eingeleitet H.C. Wainwright Buy

Entrada Therapeutics Inc Aktie (TRDA) Neueste Nachrichten

pulisher
Jul 22, 2025

What analysts say about Entrada Therapeutics Inc. stockSuperior trading gains - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Entrada Therapeutics Inc. stock priceFree Investment Community - Autocar Professional

Jul 22, 2025
pulisher
Jul 22, 2025

Is Entrada Therapeutics Inc. a good long term investmentHigh-octane financial growth - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Entrada Therapeutics Inc. Stock Analysis and ForecastStrongest growth potential - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 15, 2025

How Entrada Therapeutics Inc. stock performs during market volatilityGrowth Optimized Stock Radar - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Entrada Therapeutics Inc. stock price move sharplyFree Stock Investment Growth Plan - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Entrada Therapeutics Inc. stock attracts strong analyst attentionControlled Risk High Reward Plan - Newser

Jul 15, 2025
pulisher
Jul 13, 2025

Allspring Global Investments Holdings LLC Has $149,000 Stock Position in Entrada Therapeutics, Inc. (NASDAQ:TRDA) - Defense World

Jul 13, 2025
pulisher
Jul 13, 2025

Entrada Therapeutics, Inc. (NASDAQ:TRDA) Shares Purchased by Allspring Global Investments Holdings LLC - Defense World

Jul 13, 2025
pulisher
Jul 11, 2025

Major Stock Sell-Offs at Entrada Therapeutics: What You Need to Know! - TipRanks

Jul 11, 2025
pulisher
Jul 11, 2025

5am Ventures v sells Entrada Therapeutics (TRDA) stock for $202k - Investing.com Nigeria

Jul 11, 2025
pulisher
Jul 11, 2025

5am Ventures v sells Entrada Therapeutics (TRDA) stock for $202k By Investing.com - Investing.com South Africa

Jul 11, 2025
pulisher
Jul 11, 2025

Entrada therapeutics (TRDA) director Parmar sells $202k in stock By Investing.com - Investing.com South Africa

Jul 11, 2025
pulisher
Jul 11, 2025

Entrada therapeutics (TRDA) director Parmar sells $202k in stock - Investing.com Australia

Jul 11, 2025
pulisher
Jul 08, 2025

(TRDA) Investment Analysis and Advice - news.stocktradersdaily.com

Jul 08, 2025
pulisher
Jul 08, 2025

Entrada Therapeutics (NASDAQ:TRDA) Shares Down 3.6% – Should You Sell? - Defense World

Jul 08, 2025
pulisher
Jul 01, 2025

Entrada Therapeutics (TRDA) 10% owners sell $866k in stock - Investing.com

Jul 01, 2025
pulisher
Jun 28, 2025

Entrada Therapeutics (NASDAQ:TRDA) Upgraded to “Hold” at Wall Street Zen - Defense World

Jun 28, 2025
pulisher
Jun 17, 2025

(TRDA) Long Term Investment Analysis - news.stocktradersdaily.com

Jun 17, 2025
pulisher
Jun 16, 2025

Harbor Capital Advisors Inc. Makes New Investment in Entrada Therapeutics, Inc. (NASDAQ:TRDA) - Defense World

Jun 16, 2025
pulisher
Jun 14, 2025

Wall Street Zen Downgrades Entrada Therapeutics (NASDAQ:TRDA) to Sell - Defense World

Jun 14, 2025
pulisher
Jun 12, 2025

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires 21,594 Shares of Entrada Therapeutics, Inc. (NASDAQ:TRDA) - Defense World

Jun 12, 2025
pulisher
Jun 12, 2025

Millennium Management LLC Sells 98,416 Shares of Entrada Therapeutics, Inc. (NASDAQ:TRDA) - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

Entrada Therapeutics Holds Virtual Annual Stockholders Meeting - TipRanks

Jun 11, 2025
pulisher
Jun 10, 2025

Entrada Therapeutics, Inc. (NASDAQ:TRDA) Holdings Raised by Bank of America Corp DE - Defense World

Jun 10, 2025
pulisher
Jun 09, 2025

Transcript : Entrada Therapeutics, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-09-2025 08 - MarketScreener

Jun 09, 2025
pulisher
Jun 06, 2025

Mackenzie Financial Corp Makes New Investment in Entrada Therapeutics, Inc. (NASDAQ:TRDA) - Defense World

Jun 06, 2025
pulisher
Jun 05, 2025

How the (TRDA) price action is used to our Advantage - news.stocktradersdaily.com

Jun 05, 2025
pulisher
Jun 04, 2025

Entrada Therapeutics, Inc. (NASDAQ:TRDA) Stock Position Trimmed by Nuveen Asset Management LLC - Defense World

Jun 04, 2025
pulisher
Jun 04, 2025

Entrada Therapeutics expands board with new director By Investing.com - Investing.com South Africa

Jun 04, 2025

Finanzdaten der Entrada Therapeutics Inc-Aktie (TRDA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.80
price up icon 0.51%
$36.10
price up icon 1.26%
$102.92
price up icon 0.14%
$26.54
price up icon 0.76%
$111.44
price up icon 2.32%
biotechnology ONC
$295.59
price up icon 1.25%
Kapitalisierung:     |  Volumen (24h):